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A conjugate of leukotriene (LT) E, and bovine serum albumin (BSA) was prepared by covalently linking 
the free amino group of the hapten to the protein using dimethyl pimelindiimidate (DMP) as coupling 
reagent. Anti-LTE, antibodies were raised in rabbits immunized with the conjugate. Binding of [3H]LTE, 
to the antibodies is inhibited by 50% with 0.63 ng LTE,, while the relative cross-reaction of LTC, and LTD, 
is 46.3% and 12.6%, respectively. Using the radioimmunoassay release of sulfidopeptide-LT (SP-LT) from 
rat gastric mucosa incubated in vitro was determined after quantitative enzymatic conversion of SP-LT to 
LTE,. It could be demonstrated that this method is suitable for determination of SP-LT in biological ma- 
terial. 
Leukotriene E4 Leukotriene C, Radioimmunoassay Dimethylpimelindiimidate 
y-Glutamyltranspeptidase 
(Rat gastric mucosa) 
1. INTRODUCTION 
Leukotriene (LT) Cd, LTD4 and LTE4, now 
known to be constituents of a slow-reacting 
substance of anaphylaxis [l-3], are potent 
mediators of inflammatory and allergic reactions 
[4]. For the quantitative determination of low 
picomole amounts of sulfidopeptide-LT (SP-LT) 
in biological material a few radioimmunoassays 
have been developed [5-lo]. Immunogenic con- 
jugates were synthesized using either LTG [6-91 
or LTD4 [5,10] as haptens. The antibodies raised 
by immunization of rabbits with such conjugates 
show various degrees of cross-reactivity with the 
heterologous SP-LT. While some of the radioim- 
munoassays are highly specific for LTG [7,9], 
other assays can be used to measure the total 
amount of homologous LT plus the extensively 
cross-reacting related SP-LT [5,6,8,10]. The total 
amount of SP-LT present in biological material 
should be measurable more exactly by quantitative 
enzymatic conversion of SP-LT to LTE4 followed 
by single step determination of this specific LT. A 
radioimmunoassay for LTE4 has, however, so far 
not been described. Here we report the synthesis of 
an immunogenic LTE4-conjugate using the bifunc- 
tional imidoester dimethyl pimelindiimidate 
(DMP) as coupling reagent. The reaction couples 
the single free amino group of the hapten to amino 
groups of the carrier protein under mild conditions 
and with high efficiency. The antibodies raised in 
rabbits by immunization with the conjugate could 
be used for a radioimmunoassay for LTE4. An im- 
munogenic LTC4-conjugate was also synthesized 
by this method. The radioimmunoassay for LTB 
was used to determine the ex vivo release of SP-LT 
from gastric mucosa of rats pretreated with the 
lipoxygenase inhibitor nordihydroguaiaretic acid 
(NDGA) or with vehicle prior to instillation of 
ethanol. Ethanol treatment has been demonstrated 
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[ll] to significantly increase the synthetic capacity 4 nCi/tube of [3H]LTE4 or [3H]LTC4 as tracers 
for SP-LT of rat gastric mucosal tissue parallel to and radioimmunoassays were performed as 
the induction of gastric damage. described [6]. 
2. MATERIALS AND METHODS 
LTB4, Cd, Dq and E4 were a generous gift of Dr 
J. Rokach (Merck Frosst Laboratories, Pointe 
Claire/Dorval, Canada). Prostaglandins, throm- 
boxane B2 and mono-hydroxyeicosatetraenoic 
acids (mono-HETEs) were a gift of Dr J. Pike (Up- 
john Co., Kalamazoo, USA). Arachidonic acid 
(>99% purity), glutathione, L-cysteine, y- 
glutamyltranspeptidase (GGT, crude, from por- 
cine kidney, 7.5 U/mg) and bovine serum albumin 
were obtained from Sigma, St. Louis, USA. DMP 
was bought from Serva, Heidelberg, FRG. 
[14,15-3H]LTE4 (spec. act. 37 Ci/mmol) and 
[14,15-3H]LTC4 (spec. act. 37 Ci/mmol) were pur- 
chased from New England Nuclear Co., Dreieich, 
FRG. 
The LTE4-immunogen was synthesized using the 
bifunctional imidoester DMP as coupling reagent. 
Briefly, 0.2 mg LTE4 and 0.05 &i 
[14,15-3H]LTE4 were mixed in 0.1 ml Tris-HCl 
buffer (0.5 mol/l, pH 8.6). The mixture was added 
to an ice-cold solution of 2.0 mg BSA in 0.2 ml of 
the Tris-HCl buffer. The clear solution was stirred 
continuously and 7.7 mg DMP, dissolved in 0.1 ml 
of the Tris-HCI buffer, was added dropwise. The 
reaction was continued at 2°C overnight. The con- 
jugate was separated from unreacted hapten by ex- 
tensive dialysis against phosphate-buffered saline 
(PBS). After dialysis the conjugate was diluted 
with PBS to a final concentration of 2 mg/ml (in 
terms of bovine serum albumin (BSA)) and stored 
at -20°C until used. From determination of the 
radioactivity of the conjugate after dialysis it was 
calculated that 7.5 mol LTEd/mol BSA had been 
coupled. For immunization 0.5 mg of the con- 
jugate (in terms of BSA) was diluted with water to 
1.0 ml, emulsified with an equal volume of com- 
plete Freund’s adjuvant and injected into the foot 
pads of two rabbits. Booster injections 
(0.1 mg/animal) were administered as described 
previously [6]. Blood was collected from the ear 
artery lo-14 days after booster injections. Other 
rabbits were immunized with a LTG-BSA- 
conjugate that had been synthesized exactly as the 
LTE4-conjugate. Binding experiments with 
For enzymatic conversion of LTC4 to LTE4 
authentic LTC4 (30-1000 pg in 0.01 ml water) or 
biological samples (0.02 ml of incubation media of 
rat gastric mucosa, see below) were mixed with 
0.01 ml (75 mu) crude GGT, dissolved in 
50 mmol/l Tris-HCI buffer, pH 8.6. The total in- 
cubation volume was 0.1 ml and contained 0.1% 
gelatine. The mixture was incubated at 37°C for 
30 min. The reaction was stopped by heat inactiva- 
tion of the enzymes (lOO’C, 2 min). Radioim- 
munological analysis of the incubates was 
performed directly in the reaction tubes. Under the 
conditions used conversion of LTG to LTE4 by 
crude GGT was complete within 30 min as deter- 
mined by high pressure liquid chromatography 
(HPLC) [l l] and did not require additional use of 
aminopeptidase. 
Male Wistar rats (200-250 g) were fasted for 
24 h with free access to water. The rats were 
treated orally with NDGA (100 mg/kg, suspended 
in 0.25% carboxymethylcellulose) or with vehicle 
30 min prior to instillation of 2.0 ml ethanol. The 
animals were killed 5 min later, gastric damage 
was assessed as ulcer index and fragments of 
gastric corpus mucosa were excised and incubated 
in oxygenated Tyrode solution as described [l 11. 
Under these conditions rat gastric mucosa has been 
shown to release mainly LTG with variable 
amounts of LTD4 and LTE4 [ll]. The total 
amounts of SP-LT in the incubation media were 
determined by the newly developed radioim- 
munoassay for LTE4 after incubation with crude 
GGT. 
Means f SE were calculated. Statistical analysis 
was performed using Student’s t-test. 
3. RESULTS AND DISCUSSION 
Both rabbits immunized with the LTE4-BSA- 
conjugate produced specific antibodies to the 
hapten within several weeks. An antiplasma ob- 
tained 8 weeks after first immunization bound 
40% of the added tritium-labelled tracer at a final 
dilution of 1: 1050. Under identical conditions 
non-specific binding of label by rabbit plasma ob- 
tained before immunization was less than 2%. The 
binding of [3H]LTE4 by the antibodies was in- 
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Table 1 LTD4 and LTE4 was 21.7 and 2.3%, respectively. 
Specificity of the radioimmunoassay for LTE4 
Ligand Nanograms Relative 
required to cross-reaction 
displace 50% (Vo) 
of bound label 
LTE., 
LTC4 
LTD4 
LTB4 
5-HETE 
11 -HETE 
12-HETE 
15-HETE 
PGEz 
PGDz 
PGF2, 
6-Keto-PGFr, 
TXB2 
Arachidonic acid 
Glutathione 
L-Cysteine 
0.63 100.00 
1.36 46.32 
5.02 12.55 
80.00 0.79 
> 100.00 < 0.60 
> 100.00 < 0.60 
> 100.00 <0.60 
> 100.00 <0.60 
> 100.00 <0.60 
> 100.00 <0.60 
> 100.00 <0.60 
> 100.00 <0.60 
> 100.00 < 0.60 
> 100.00 < 0.60 
> 100.00 <0.60 
> 100.00 <0.60 
Imidoesters have been used so far for 
biochemical purposes such as modification of 
amino groups [12,13] or protein cross-linking 
[14,15]. The mechanism of the reaction of im- 
idoesters with amines is well defined [12,16] 
resulting in the formation of a homogeneous type 
of conjugate under very mild conditions. The reac- 
tion is, therefore, suitable for the synthesis of im- 
munogenic conjugates of biologically active 
haptens. DMP provides a 7 carbon spacer exposing 
the SP-LT molecule in a distance of about 10 A 
from the BSA carrier. Consequently, the an- 
tibodies raised recognize not only differences in the 
fatty acid moiety, but also in the peptide moiety of 
the LT molecules. On the other hand, as LTC4 
cross-reacts more extensively with the anti-LTE4 
antibodies than LTD4, part of the coupling reagent 
seems to resemble the 5 carbon chain of the y- 
glutamyl residue of the LTC4 molecule. 
hibited by unlabelled LTE4 in a competitive man- 
ner. 50% inhibition of binding of label was 
observed with 630 pg LTE4 (table 1) and 10% in- 
hibition, defined as detection limit of the assay, 
was obtained with 70 pg LTE4. The relative cross- 
reaction of LTCd and LTD4 was 46.3 and 12.6%, 
respectively (table 1). Various prostaglandins, 
thromboxane Bz, mono-HETEs, arachidonic acid, 
glutathione and L-cysteine do not interfere 
significantly with the assay in amounts up to 
100 ng. LTB4, on the other hand, which like the 
SP-LT contains the triene structure, exhibits a 
slight, but measurable interference of less than 1% 
(table 1). As a measure of assay precision the intra- 
assay and inter-assay coefficients of variation at 4 
different amounts of LTE4 (250, 500, 1000 and 
2000 pg) were determined. At these levels the intra- 
assay coefficients of variation were 7.7, 3.2, 2.1 
and 1.6%, respectively (n = 5 each), while the 
inter-assay coefficients of variation were 13.6, 
14.5, 13.4 and 15.4070, respectively (n = 5 each). 
The anti-LTG antibodies raised in rabbits by im- 
munization with the LTCd-DMP-BSA-conjugate 
recognized the homologous hapten LTCd best 
(50% inhibition of binding of label to antibodies 
by 285 pg), while the relative cross-reaction of 
Quantitative conversion of LTC4 to LTE4 as 
determined by HPLC is observed after incubation 
with crude GGT at 37°C for 30 min. As shown in 
fig.1 values of immunoreactive LTE4 measured 
after enzyme treatment of standard amounts of 
LTG by the newly developed radioimmunoassay 
correlate excellently (r = 0.9989, n = 7, p < 0.001) 
with values of LTG measured without enzyme 
0 5 10 15 20 
PICOMOLES LTCL ADDED 
Fig. 1. Correlation between standard amounts of LTC4 
and the corresponding amounts of immunoreactive 
LTE4 resulting from treatment of LTC4 with crude y- 
glutamyltranspeptidase (75 mu/tube) at 37°C for 
30 min. 
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treatment. The radioimmunoassay for LTE4 was 
used for the quantitative determination of SP-LT 
release from rat gastric mucosa incubated ex vivo 
5 min after ethanol instillation. As reported [l l] 
SP-LT released under such conditions consist 
mainly of LTC4 with smaller amounts of LTD4 
and LTE4. Fig.2 illustrates values of immunoreac- 
tive LTE4 observed in rat gastric mucosal incuba- 
tion media after quantitative enzymatic conversion 
of SP-LT to LTE4. Pretreatment of rats with the 
lipoxygenase inhibitor NDGA (100 mg/kg) 
decreases release of total SP-LT (determined as im- 
munoreactive LTE4) from gastric mucosa as com- 
pared to the mucosa of rats that had received the 
vehicle prior to ethanol. As shown in fig.2 and 
described in [ 1 l] inhibition of gastric mucosal SP- 
LT release is paralleled by gastric protection 
against the damaging effect of ethanol. 
Our results show that quantitative enzymatic 
conversion of SP-LT followed by single step 
radioimmunological measurement of LTE4 is a 
suitable method for determination of SP-LT in 
biological material. Alternatively, the various SP- 
LT could be separated by HPLC and quantitative 
determinations could be performed in eluted frac- 
tions [5,10,17]. This method is time-consuming 
and results in many more samples than determina- 
120, rl200 5 _ 
1000 
800 
600 
LOO 
200 
0 
CONTROL NDGA 
IlOOmglkg 1
Fig.2. Ulcer index (hatched bars) and total amounts of 
SP-LT, determined as LTE.+-like immunoreactivity after 
quantitative enzymatic conversion of SP-LT to LTB 
(open bars), released from rat gastric mucosa incubated 
at 37°C for 10 min ex vivo 5 min after oral instillation 
of 2.0 ml ethanol. NDGA (100 mg/kg), suspended in 
0.25% carboxymethylcellulose (2.5 ml/kg) was given 
orally 30 min prior to ethanol, while control rats 
received the corresponding volume of 0.25% 
carboxymethylcellulose 30 min prior to ethanol. 
oo p < 0.001; l p < 0.005 as compared to control rats. 
tion of LTE4 as an index of total SP-LT. The 
radioimmunoassay for LTE4 might be of par- 
ticular value, when the synthetic capacity for SP- 
LT is determined in tissues, which effectively con- 
vert LTG to LTE4 such as the human 
gastrointestinal tract [ 181. Furthermore, since 
LTE4 seems to occur in human bile [19] and is a 
urinary metabolite of LTC4 in man [20], the 
radioimmunoassay for LTE4 might be valuable for 
determination of the systemic biosynthesis and ex- 
cretion of SP-LT under physiological and 
pathophysiological conditions in man. 
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